Manhattan Research, LLC Blog The Evolving Orphan Drug Market: What Does the Future Hold?

Patients with very rare diseases, in addition to the consequences of their disease, also suffer at the hands of market forces. The cost of developing drugs is high, and there is a small market for drugs for rare diseases. Without incentives, this market is consequently unattractive for pharmaceutical companies who must allocate their resources to […] The post The Evolving Orphan Drug Market: What Does the Future Hold? appeared first on DRG.